HYDREA 830 HYDREA 830 (Hydrea 500 mg)
Generic Name: hydroxyurea
Pill imprint HYDREA 830 HYDREA 830 has been identified as Hydrea 500 mg.
Hydrea is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydrea 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for HYDREA 830 HYDREA 830 (Hydrea 500 mg)
- Generic Name:
- 500 mg
- Pink & Turquoise
- 22.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
- Inactive Ingredients:
- citric acid
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 40
D&C Red No. 28
|NDC Code||Manufacturer / Repackager|
|54868-1367||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
Hydrea is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...